explore -WSS

explore

author：hotspot 2025-10-04 04:01:05 - browse：177

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Wikipedia

focus

WSS

American TikTok star stuck in Dubai for months following rental car altercation

FogPharma raises $145 million in rare Series E round

How to address the problem of discarded donor organs

Change Healthcare cyberattack outage could last weeks

Congress gives doctors Medicare pay bump

Doctors in states that ban abortion can still help patients

focus

explore

explore

Hepatitis C has a cure — but many Americans still lack access to it

In search for therapies for solid tumors, companies turn to claudin

Cancer drug shortages should be causing more outrage

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

ChatGPT in medicine: STAT answers readers' burning questions

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

After affirmative action ruling, medical educators look to 'holistic review'

RSV vaccines may be linked to small increased risk of developing GBS

DIEP, the 'gold standard' of breast reconstruction, is under threat

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

hotspot

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Medical device lobby: We're tired of waiting on Medicare coverage

Biotech companies concerned about China biosecurity crackdown

Russian and Belarusian players banned from a women's tennis tournament in Prague

focus

Wikipedia

focus

leisure time